MARCOS
GONZÁLEZ DÍAZ
Researcher in the period 1993-2023
Center for Cancer and Blood Disorders
Fort Worth, Estados UnidosPublications in collaboration with researchers from Center for Cancer and Blood Disorders (1)
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477